Related Experiment Video

Updated: Aug 15, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
23:33

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation

Published on: February 28, 2012

Interaction of antibiotics and warfarin in pediatric cardiology patients

M C Johnson1, M Wood, V Vaughn

  • 1Division of Pediatric Cardiology, Department of Pediatrics, Washington University School of Medicine/St. Louis Children's Hospital, 1 Children's Place, St. Louis, MO 63110, USA. Johnson_m@kids.wustl.edu

Pediatric Cardiology
|October 20, 2005
PubMed

Insights

Antibiotic use increases the risk of excessive anticoagulation in children taking warfarin. Closer monitoring of the international normalized ratio (INR) is recommended when children on warfarin start antibiotic therapy.

Area of Science:

  • Pharmacology
  • Pediatrics
  • Clinical Medicine

Background:

  • Warfarin is a common anticoagulant medication.
  • Antibiotics are known to interact with warfarin in adults, affecting anticoagulation.
  • The impact of antibiotic-warfarin interactions in pediatric patients is not well-established.

Purpose of the Study:

  • To investigate the effect of antibiotic therapy on anticoagulation in pediatric patients receiving warfarin.
  • To determine if there is a correlation between patient age and the alteration in anticoagulation.
  • To provide evidence-based recommendations for managing warfarin therapy during antibiotic treatment in children.

Main Methods:

  • Retrospective review of medical records of patients under 21 years old treated with warfarin.
  • Analysis of international normalized ratio (INR) levels before and during antibiotic therapy.
  • Statistical analysis to assess the change in INR and its correlation with patient age.

Main Results:

  • Antibiotic therapy was associated with a significant increase in the mean INR from 2.7 to 3.6 in pediatric patients.
  • The magnitude of INR increase was inversely correlated with patient age, with younger children experiencing greater changes.
  • 89 courses of antibiotics were administered to 23 patients during the study period.

Conclusions:

  • Antibiotic use can lead to excessive anticoagulation in children on warfarin.
  • Younger pediatric patients are at higher risk for significant INR fluctuations during antibiotic treatment.
  • Intensified INR monitoring is crucial when initiating antibiotic therapy in pediatric patients receiving warfarin to prevent adverse events.

Related Concept Videos

Pharmacokinetics: Drug–Food and Drug–Viral Interactions01:26

Pharmacokinetics: Drug–Food and Drug–Viral Interactions

A drug interaction occurs when the concurrent use of another drug, food, or an external substance alters the pharmacological activity of a drug. This interaction can modify the action of the original drug, affecting its effectiveness and safety.Drug–food interactions are significant as they impact drug absorption, metabolism, and excretion. For example, grapefruit juice is a well-known disruptor of drug metabolism. It inhibits the cytochrome P450 3A4 enzyme, crucial for the metabolism of many...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...